A new three-phase screening protocol that incorporates a PSA test, a four-kallikrein panel, and an MRI scan appears to improve the prostate cancer detection rate among men invited to participate in a ...

Protocol-directed prostate cancer active surveillance offers acceptable oncologic safety. Protocol-directed active surveillance of localized prostate cancer reduces unnecessary treatment of men ...

Sexual Function Retained in Prostate Cancer Combination Therapy Researchers compared targeted prostate biopsy based on biparametric magnetic resonance imaging with standard 12-core systematic biopsy.

On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...

Discover a study showing how optimised prostate biopsy strategies improve detection of transitional zone tumours while ...

Targeting prostate-specific membrane antigen, Lu-PSMA-617 has demonstrated clinical benefits in patients with PSMA-positive ...

Although 6 months of androgen deprivation did not produce an overall survival (OS) advantage, it was associated with improvements in rates of biochemical failure, distant metastases (DMs), and ...

Prostate cancer patients with T2c-T4 prostate cancer with no extra pelvic lymph node involvement and prostate-specific antigen (PSA) less than 150 ng/mL were included. All patients received 4 months ...

BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...

Jan. 9 (UPI) --Defense Secretary Lloyd Austin is in treatment for prostate cancer and recently underwent surgery, Walter Reed National Military Medical Center said in a statement on Tuesday. A ...